China's top scientist Wu Yiling's wealth declined by $2 billion after shares of his company, Shijiazhuang Yiling Pharmaceutical, plunged 35% in the past two weeks. The company's stock fell after the son of a Chinese tycoon questioned the efficacy of Wu's drug used to treat COVID-19. The medicine has also been recommended by the Chinese government for treating mild cases.